Description

Mounjaro (tirzepatide) is a weekly, prescription-only, subcutaneous injection used to improve blood sugar control in adults with type 2 diabetes and for chronic weight management. By acting as a dual GIP and GLP-1 receptor agonist, it boosts insulin secretion, slows digestion, and reduces hunger . It is administered in the abdomen, thigh, or upper arm .    Key Information on Mounjaro Injection Active Ingredient: Tirzepatide. Uses: Type 2 diabetes management and weight loss (often for BMI    30 or    27 with weight-related conditions). Administration: Once weekly injection under the skin (subcutaneous) in the abdomen, thigh, or upper arm. Dosage: Treatment typically starts at 2.5 mg for 4 weeks, increasing to 5 mg, with a maximum dose of 15 mg. Common Side Effects: Nausea, diarrhea, vomiting, constipation, and injection site reactions. Warnings: Carries a boxed warning for the potential risk of thyroid C-cell tumors.   How to Use Weekly Schedule: Inject on the same day each week, with or without meals. Site Rotation: Change (rotate) the injection site with each dose to avoid skin irritation. Procedure: Check the liquid to ensure it is clear, use a new needle for each injection, and follow the instructions provided with the pen. Missed Dose: If a dose is missed, take it as soon as possible within 4 days (96 hours).   Important Considerations Not for Type 1 Diabetes: Mounjaro is not approved for type 1 diabetes or treatment of diabetic ketoacidosis. Lifestyle Changes: Mounjaro is designed to be used in conjunction with a healthy diet and regular physical activity. Consultation: Always use under the supervision of a healthcare professional to monitor for potential side effects and determine the appropriate dosage.